The Food and Drug Administration (FDA) approved Zyprexa in 1996 for use in treatment of bipolar disorder and schizophrenia. Since its introduction, Zyprexa use expanded to be prescribed to treat psychotic disorder patients, Alzheimer's patients, personality disorder sufferers, conduct disorders, and severe aggression in children. As Zyprexa's usage grew, so did concerns over the health of patients taking the drug. In November 2001, studies indicated possible links between Zyprexa and serious and deadly side effects. The FDA reported possible links between Zyprexa and hyperglycemia and to diabetes. Approximately 400 Zyprexa patients have reported the development of diabetes and more than 20 have died. As a result of these studies, Zyprexa manufacturer, Eli Lilly, was required to add warnings to its packaging by governments in Japan and throughout Europe. At present, Zyprexa is the world's best selling schizophrenia drug.
Since its release to the public, studies have linked Zyprexa to serious health conditions including hyperglycemia, diabetes, obesity, and high blood pressure. Deaths and serious injuries have been reported. However, the drug remains to be widely prescribed and is the leading prescription drug for some ailments. If you or a loved one has taken Zyprexa, also known as olanzapine), we will evaluate your case absolutely free. If Zyprexa has injured you or a loved one, our legal team will aggressively fight for your rights. You may be entitled to compensation.
- Utah Snags $24 Million in Pharmaceutical Drug Settlement - Nov 12 2009
- Investigation of Broward Child's Suicide Turns to Psychiatric Drugs - Apr 23 2009
- Lilly Close to $1.4 Billion Settlement over Zyprexa - Jan 15 2009